Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 11, 2026 08:45 ET | Source: Amplia Therapuetics Limited

Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial

Melbourne, Australia, Feb. 11, 2026 (GLOBE NEWSWIRE) -- HIGHLIGHTS Two US-based sites have completed trial initiation activities for the AMPLICITY trial in pancreatic cancer These sites join the...
February 11, 2026 06:33 ET | Source: SNS Insider pvt ltd

Clinical Perinatal Software Market to Reach USD 542.86 Million by 2033, Driven by Rising Focus on Maternal and Neonatal Care – SNS Insider

Austin, United States, Feb. 11, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the Clinical Perinatal Software Market size is valued at USD 237.10 Million in 2025 and is expected to reach USD...
February 11, 2026 03:30 ET | Source: Custom Market Insights

[Latest] Global Cell Therapy Raw Materials Market Size/Share Worth USD 29.3 Billion by 2035 at a 18.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cell Therapy Raw Materials Market Size, Trends and Insights By Product (Media,...
February 11, 2026 02:00 ET | Source: Reset Health

Reset Health Further Strengthens Advisory Board With Appointment of Pinder Sahota

LONDON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Reset Health (“the Company”), the experts in the personalised management of chronic disease, today announces Pinder Sahota has joined the Company as a...
February 10, 2026 12:51 ET | Source: AstuteAnalytica India Pvt. Ltd.

Clinical Communication and Collaboration Market to Reach US$ 9,430 Million by 2033 as Telemedicine and Cloud-Based Care Accelerate | Astute Analytica

Chicago, Feb. 10, 2026 (GLOBE NEWSWIRE) -- According to recent data from Astute Analytica, the global clinical communication and collaboration market was valued at US$ 2,942.90 million in 2024 and...
February 10, 2026 08:00 ET | Source: Cogent Biosciences, Inc.

Cogent Biosciences Announces Multiple SUMMIT Posters at the 2026 AAAAI Annual Meeting

WALTHAM, Mass. and BOULDER, Colo., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically...
February 10, 2026 07:00 ET | Source: 4basebio

Leadership Changes

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION...
February 10, 2026 07:00 ET | Source: Kailera Therapeutics, Inc.

Kailera Therapeutics and Hengrui Pharma Report Positive Topline Data from Phase 2 Obesity Trial of Oral Ribupatide

Kailera and Hengrui report positive topline data from Hengrui’s Phase 2 clinical trial of oral ribupatide, a GLP-1/GIP receptor dual agonist peptide.
February 09, 2026 08:00 ET | Source: Oryzon Genomics, S.A.

ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in Extensive Stage Small Cell Lung Cancer

Exploring the combination with atezolizumab and radiation therapyStudy led by Yale University MADRID, Spain and CAMBRIDGE, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code:...
February 09, 2026 07:00 ET | Source: Can-Fite BioPharma Ltd.

Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy

Namodenoson’s oral safety profile and metabolic activity, position it as a promising candidate in the rapidly growing obesity treatment market Ramat Gan, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- ...